Market Research Future (MRFR) announces the publication of its research report Global Atorvastatin API Market, 2018–2023. Atorvastatin API Market: Information by Application (Hypercholesterolemia, Hypertriglyceridemia, Dyslipidemia) and Region (North America, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2023
The global atorvastatin API market is projected to grow at a CAGR of 3.34%. The high adoption of atorvastatin in the treatment of cardiovascular diseases is expected to boost the market growth. However, adverse health effects associated with atorvastatin are likely to restrain market growth.
North America accounted for the largest market share for atorvastatin API and is projected to register a CAGR of 3.10% during the forecast period. The US is expected to be the leading markets in the region, accounting for the largest projected market share during the review period. It is also expected to exhibit a CAGR of 2.83% during the forecast period. The high prevalence of hypercholesterolemia is fueling the growth of the atorvastatin API market in this region.
Request Free Sample at https://www.marketresearchfuture.com/sample_request/7885
Europe held a prominent share of the global atorvastatin API market in 2017. The UK, France, and Spain are the major contributors to the growth of the European atorvastatin API market. High prevalence of hypercholesterolemia and mixed dyslipidemia are driving the regional market growth.
Asia-Pacific is also expected to account for a significant share of the global atorvastatin API market, and the regional market is projected to grow at the fastest CAGR during the forecast period. Increasing prevalence of dyslipidemia is expected to impact the growth of the Asia-Pacific atorvastatin API market positively. The Chinese market is expected to maintain its dominance in the regional market during the review period. It is also projected to register the highest CAGR during the forecast period.
The Middle East accounted for the largest share of the market in the Middle East and Africa region in 2017. However, the African market is expected to register the fastest CAGR of 4.38% during the forecast period.
The global atorvastatin API market has been segmented on the basis of application, and region. On the basis of the application, the market has been divided into hypercholesterolemia, hypertriglyceridemia, dyslipidemia, and others. The hypercholesterolemia segment held the majority market share in 2017. It is also expected to be the fastest-growing segment, followed by the hypertriglyceridemia segment. Rising prevalence of hypercholesterolemia is driving the growth of the segment.
Some of the key players in the global atorvastatin API market are Teva Pharmaceutical Industries Ltd (Israel), Jubilant Life Sciences Ltd (India), Dr. Reddy’s Laboratories Ltd (India), Sun Pharmaceutical Industries Ltd (India), Ind-Swift Labs Ltd (India), Morepen Laboratories Ltd (India), Zhejiang Hisun Pharmaceutical Co Ltd (China), Anuh Pharma Ltd (India), Centrient Pharmaceuticals (The Netherlands), and Cadila Pharmaceuticals (India).
TABLE OF CONTENTS
1 Executive Summary$ 1,350.00
1.1 Market Attractiveness Analysis 14
1.1.1 Global Atorvastatin API Market, By Application 15
1.1.2 Global Atorvastatin API Market, By Region 16
2 Market Introduction$ 0.00
2.1 Definition 17
2.2 Scope Of The Study 17
2.3 Market Structure 17
3 Research Methodology$ 0.00
3.1 Research Process 18
3.2 Primary Research 19
3.3 Secondary Research 20
3.4 Market Size Estimation 20
3.5 Forecast Model 21
3.6 List Of Assumptions 22
4 Market Dynamics$ 950.00
4.1 Introduction 23
4.2 Drivers 24
4.2.1 High Adoption Of Atorvastatin In The Treatment Of Cardiovascular Diseases 24
4.2.2 Drivers Impact Analysis 24
4.3 Restraints 25
4.3.1 Adverse Health Effects Associated With Atorvastatin 25
4.3.2 Restraints Impact Analysis 25
4.4 Opportunities 26
4.4.1 Growing Prevalence Of Dyslipidemia In China 26
5 Market Factor Analysis$ 950.00
5.1 Value Chain Analysis 27
5.1.1 Research And Development 27
5.1.2 Manufacturing 27
5.1.3 Distribution & Sale 28
5.1.4 Post-Sale Monitoring 28
5.2 Porter’s Five Forces Model 28
5.2.1 Threat Of New Entrants 29
5.2.2 Intensity Of Rivalry 29
5.2.3 Threat Of Substitutes 29
5.2.4 Bargaining Power Of Suppliers 29
5.2.5 Bargaining Power Of Buyers 29
To view the full report, visit at https://www.marketresearchfuture.com/reports/atorvastatin-api-market-7885
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312